Literature DB >> 16340727

In-vivo visualization of radiation-induced apoptosis using (125)I-annexin V.

Hiroshige Watanabe1, Yuji Murata, Masahiko Miura, Masatoshi Hasegawa, Tadafumi Kawamoto, Hitoshi Shibuya.   

Abstract

BACKGROUND: As apoptosis occurs in tumors within a short time after irradiation, the detection of the frequency of apoptosis may be useful as an indicator of the effect of treatment. For the evaluation of apoptosis under these conditions, tissue extraction from patients is indispensable. AIM: To develop a noninvasive imaging technique to measure and monitor apoptosis in tumor cells caused by X-irradiation using (125)I-radiolabeled annexin V.
METHODS: The tumors used were human ependymoblastomas, which were transplanted into nude mice. The tumors were irradiated at 2, 5 or 10 Gy. (125)I-annexin V was administered intravenously 6 h after irradiation. In the 5 Gy irradiation group, the isotope was injected at various time intervals (3, 6 and 12 h) after irradiation. Three hours after the injection, the mice were sacrificed, the tumors were quickly removed and frozen sections were prepared at 6 and 40 microm thickness using a cryomicrotome. In autoradiographic imaging, the tumor-to-muscle ratios were compared in the respective irradiated groups. In addition, apoptosis detection by the in-situ end-labeling (Klenow) assay was conducted on the same sections. The number of Klenow-positive cells was counted in 100 x fields for each section.
RESULTS: Both autoradiography and immunohistochemical staining showed a significantly higher frequency of apoptosis in the neoplasms in all irradiated groups than in the control group (P<0.05). Although immunohistochemical staining revealed a peak apoptosis frequency in the 5 Gy irradiated group, autoradiography revealed a peak in the group receiving a lower dose than 5 Gy. When the time from irradiation to annexin injection was varied, both imaging methods showed a peak apoptosis frequency in the group receiving the injection 6 h after irradiation.
CONCLUSION: It is possible to predict the effect of treatment in cancer in a noninvasive manner by apoptosis imaging in vivo after radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16340727     DOI: 10.1097/01.mnm.0000189778.60496.30

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  7 in total

1.  Synthesis of ApoSense compound [18F]2-(5-(dimethylamino)naphthalene-1-sulfonamido)-2-(fluoromethyl)butanoic acid ([18F]NST732) by nucleophilic ring opening of an aziridine precursor.

Authors:  Falguni Basuli; Haitao Wu; Zhen-Dan Shi; Bao Teng; Changhui Li; Agnieszka Sulima; Aaron Bate; Philip Young; Mathew McMillan; Gary L Griffiths
Journal:  Nucl Med Biol       Date:  2012-02-14       Impact factor: 2.408

2.  Use of a fluorescently labeled poly-caspase inhibitor for in vivo detection of apoptosis related to vascular-targeting agent arsenic trioxide for cancer therapy.

Authors:  R J Griffin; B W Williams; J C Bischof; M Olin; G L Johnson; B W Lee
Journal:  Technol Cancer Res Treat       Date:  2007-12

3.  Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications.

Authors:  Mehdi Azizi; Hassan Dianat-Moghadam; Roya Salehi; Masoud Farshbaf; Disha Iyengar; Samaresh Sau; Arun K Iyer; Hadi Valizadeh; Mohammad Mehrmohammadi; Michael R Hamblin
Journal:  Adv Funct Mater       Date:  2020-03-03       Impact factor: 18.808

4.  Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair.

Authors:  Rajesh P Rastogi; Ashok Kumar; Madhu B Tyagi; Rajeshwar P Sinha
Journal:  J Nucleic Acids       Date:  2010-12-16

5.  Noninvasive targeting delivery and in vivo magnetic resonance tracking method for live apoptotic cells in cerebral ischemia with functional Fe2O3 magnetic nanoparticles.

Authors:  Atsushi Saito; Moataz M Mekawy; Akira Sumiyoshi; Jorge J Riera; Hiroaki Shimizu; Ryuta Kawashima; Teiji Tominaga
Journal:  J Nanobiotechnology       Date:  2016-03-11       Impact factor: 10.435

6.  Preliminary biological evaluation of 18F-AlF-NOTA-MAL-Cys-Annexin V as a novel apoptosis imaging agent.

Authors:  Chunxiong Lu; Quanfu Jiang; Minjin Hu; Cheng Tan; Huixin Yu; Zichun Hua
Journal:  Oncotarget       Date:  2017-04-10

Review 7.  Avenues to molecular imaging of dying cells: Focus on cancer.

Authors:  Anna A Rybczynska; Hendrikus H Boersma; Steven de Jong; Jourik A Gietema; Walter Noordzij; Rudi A J O Dierckx; Philip H Elsinga; Aren van Waarde
Journal:  Med Res Rev       Date:  2018-03-12       Impact factor: 12.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.